Cornelis J F van Noorden
Overview
Explore the profile of Cornelis J F van Noorden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
167
Citations
5053
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Kastelein A, Vos L, van Baal J, Koning J, Hira V, Nieuwland R, et al.
Clin Exp Metastasis
. 2020 Feb;
37(2):293-304.
PMID: 32008138
Most women with epithelial ovarian cancer (EOC) suffer from peritoneal carcinomatosis upon first clinical presentation. Extensive peritoneal carcinomatosis has a poor prognosis and its pathophysiology is not well understood. Although...
22.
Hira V, Breznik B, Vittori M, Loncq de Jong A, Mlakar J, Oostra R, et al.
J Histochem Cytochem
. 2019 Oct;
68(1):33-57.
PMID: 31566074
Glioblastoma is the most aggressive primary brain tumor. Slowly dividing and therapy-resistant glioblastoma stem cells (GSCs) reside in protective peri-arteriolar niches and are held responsible for glioblastoma recurrence. Recently, we...
23.
Yetkin-Arik B, Vogels I, Nowak-Sliwinska P, Weiss A, Houtkooper R, van Noorden C, et al.
Sci Rep
. 2019 Sep;
9(1):12608.
PMID: 31471554
During sprouting angiogenesis, an individual endothelial tip cell grows out from a pre-existing vascular network and guides following and proliferating stalk cells to form a new vessel. Metabolic pathways such...
24.
Rotoli D, Morales M, Maeso M, Avila J, Perez-Rodriguez N, Mobasheri A, et al.
J Histochem Cytochem
. 2019 Feb;
67(7):481-494.
PMID: 30794467
Glioblastoma (GB) is the most frequently occurring and aggressive primary brain tumor. Glioma stem cells (GSCs) and astrocytoma cells are the predominant malignant cells occurring in GB besides a highly...
25.
van der Wijk A, Wisniewska-Kruk J, Vogels I, van Veen H, Ip W, van der Wel N, et al.
FASEB J
. 2019 Jan;
33(4):5320-5333.
PMID: 30698992
Insight into the molecular and cellular processes in blood-retinal barrier (BRB) development, including the contribution of paracellular and transcellular pathways, is still incomplete but may help to understand the inverse...
26.
Hira V, Loncq de Jong A, Ferro K, Khurshed M, Molenaar R, van Noorden C
Acta Histochem
. 2018 Nov;
121(2):125-134.
PMID: 30454859
Immunohistochemistry (IHC) specifically localizes proteins in cells and tissues, but methodologies vary widely. Therefore, we performed a methodological IHC optimization and validation study. First, we compared advantages and disadvantages of...
27.
Breznik B, Limback C, Porcnik A, Blejec A, Koprivnikar Krajnc M, Bosnjak R, et al.
Radiol Oncol
. 2018 Oct;
52(4):433-442.
PMID: 30367810
Background Glioblastoma is a highly aggressive central nervous system neoplasm characterized by extensive infiltration of malignant cells into brain parenchyma, thus preventing complete tumor eradication. Cysteine cathepsins B, S, L...
28.
Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature
Kastelein A, Vos L, de Jong K, van Baal J, Nieuwland R, van Noorden C, et al.
Semin Cell Dev Biol
. 2018 Sep;
92:27-36.
PMID: 30253239
The peritoneum is a large serous membrane with both epithelial and mesenchymal features, and is essential for maintaining an intra-abdominal homeostatic equilibrium. The peritoneum plays a central role in the...
29.
Bosma E, van Noorden C, Schlingemann R, Klaassen I
Fluids Barriers CNS
. 2018 Sep;
15(1):24.
PMID: 30231925
Breakdown of the blood-brain barrier (BBB) or inner blood-retinal barrier (BRB), induced by pathologically elevated levels of vascular endothelial growth factor (VEGF) or other mediators, can lead to vasogenic edema...
30.
van der Wijk A, Canning P, van Heijningen R, Vogels I, van Noorden C, Klaassen I, et al.
Acta Ophthalmol
. 2018 Sep;
97(2):214-224.
PMID: 30168271
Purpose: Glucocorticoids (GCs) are used as treatment in diabetic macular oedema, a condition caused by blood-retinal barrier (BRB) disruption. The proposed mechanisms by which GCs reduce macular oedema are indirect...